COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02553187
Recruitment Status : Unknown
Verified February 2017 by Zhejiang Kanglaite Pharmaceutical Co.Ltd.
Recruitment status was:  Recruiting
First Posted : September 17, 2015
Last Update Posted : February 15, 2017
H & J CRO International, Inc.
Information provided by (Responsible Party):
Zhejiang Kanglaite Pharmaceutical Co.Ltd

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2017
Estimated Study Completion Date : July 2018